# Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma

> **NCT06563102** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 101 (actual)

## Conditions studied

- Mild Asthma

## Interventions

- **COMBINATION_PRODUCT:** Albuterol/Budesonide
- **COMBINATION_PRODUCT:** Albuterol

## Key facts

- **NCT ID:** NCT06563102
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-11
- **Primary completion:** 2026-02-24
- **Final completion:** 2026-02-24
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06563102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06563102, "Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06563102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*